196 related articles for article (PubMed ID: 35200164)
1. Stem cell-derived retinal pigment epithelium transplantation in age-related macular degeneration: recent advances and challenges.
Kashani AH
Curr Opin Ophthalmol; 2022 May; 33(3):211-218. PubMed ID: 35200164
[TBL] [Abstract][Full Text] [Related]
2. Stem cell based therapies for age-related macular degeneration: The promises and the challenges.
Nazari H; Zhang L; Zhu D; Chader GJ; Falabella P; Stefanini F; Rowland T; Clegg DO; Kashani AH; Hinton DR; Humayun MS
Prog Retin Eye Res; 2015 Sep; 48():1-39. PubMed ID: 26113213
[TBL] [Abstract][Full Text] [Related]
3. Human-induced pluripotent stem cells-derived retinal pigmented epithelium, a new horizon for cells-based therapies for age-related macular degeneration.
Dehghan S; Mirshahi R; Shoae-Hassani A; Naseripour M
Stem Cell Res Ther; 2022 May; 13(1):217. PubMed ID: 35619143
[TBL] [Abstract][Full Text] [Related]
4. Stem Cell Therapy in Nonneovascular Age-Related Macular Degeneration.
Kashani AH
Invest Ophthalmol Vis Sci; 2016 Apr; 57(5):ORSFm1-9. PubMed ID: 27116669
[TBL] [Abstract][Full Text] [Related]
5. Cell-Based Therapies for Age-Related Macular Degeneration.
Khateb S; Jha S; Bharti K; Banin E
Adv Exp Med Biol; 2021; 1256():265-293. PubMed ID: 33848006
[TBL] [Abstract][Full Text] [Related]
6. A bioengineered retinal pigment epithelial monolayer for advanced, dry age-related macular degeneration.
Kashani AH; Lebkowski JS; Rahhal FM; Avery RL; Salehi-Had H; Dang W; Lin CM; Mitra D; Zhu D; Thomas BB; Hikita ST; Pennington BO; Johnson LV; Clegg DO; Hinton DR; Humayun MS
Sci Transl Med; 2018 Apr; 10(435):. PubMed ID: 29618560
[TBL] [Abstract][Full Text] [Related]
7. Advancing a Stem Cell Therapy for Age-Related Macular Degeneration.
O'Neill HC; Limnios IJ; Barnett NL
Curr Stem Cell Res Ther; 2020; 15(2):89-97. PubMed ID: 31854278
[TBL] [Abstract][Full Text] [Related]
8. Cell-based therapies for retinal diseases: a review of clinical trials and direct to consumer "cell therapy" clinics.
Hinkle JW; Mahmoudzadeh R; Kuriyan AE
Stem Cell Res Ther; 2021 Oct; 12(1):538. PubMed ID: 34635174
[TBL] [Abstract][Full Text] [Related]
9. Stem Cell-Based Therapy for Diseases of the Retinal Pigment Epithelium: From Bench to Bedside.
Sachdeva MM; Eliott D
Semin Ophthalmol; 2016; 31(1-2):25-9. PubMed ID: 26959126
[TBL] [Abstract][Full Text] [Related]
10. Stem cell therapies for age-related macular degeneration: the past, present, and future.
Dang Y; Zhang C; Zhu Y
Clin Interv Aging; 2015; 10():255-64. PubMed ID: 25609937
[TBL] [Abstract][Full Text] [Related]
11. Treatment of Age-Related Macular Degeneration with Pluripotent Stem Cell-Derived Retinal Pigment Epithelium.
Vitillo L; Tovell VE; Coffey P
Curr Eye Res; 2020 Mar; 45(3):361-371. PubMed ID: 31777296
[TBL] [Abstract][Full Text] [Related]
12. [Preclinical Study of Human Induced Pluripotent Stem Cell-derived Retinal Pigment Epithelium Cell Sheets Transplantation].
Kamao H
Nippon Ganka Gakkai Zasshi; 2016 Nov; 120(11):754-63. PubMed ID: 30074740
[TBL] [Abstract][Full Text] [Related]
13. Pluripotent Stem Cells in Clinical Cell Transplantation: Focusing on Induced Pluripotent Stem Cell-Derived RPE Cell Therapy in Age-Related Macular Degeneration.
Yang YP; Hsiao YJ; Chang KJ; Foustine S; Ko YL; Tsai YC; Tai HY; Ko YC; Chiou SH; Lin TC; Chen SJ; Chien Y; Hwang DK
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430270
[TBL] [Abstract][Full Text] [Related]
14. Utilizing stem cell-derived RPE cells as a therapeutic intervention for age-related macular degeneration.
Westenskow PD; Kurihara T; Friedlander M
Adv Exp Med Biol; 2014; 801():323-9. PubMed ID: 24664714
[TBL] [Abstract][Full Text] [Related]
15. Tumorigenicity studies of induced pluripotent stem cell (iPSC)-derived retinal pigment epithelium (RPE) for the treatment of age-related macular degeneration.
Kanemura H; Go MJ; Shikamura M; Nishishita N; Sakai N; Kamao H; Mandai M; Morinaga C; Takahashi M; Kawamata S
PLoS One; 2014; 9(1):e85336. PubMed ID: 24454843
[TBL] [Abstract][Full Text] [Related]
16. Looking into the future: Using induced pluripotent stem cells to build two and three dimensional ocular tissue for cell therapy and disease modeling.
Song MJ; Bharti K
Brain Res; 2016 May; 1638(Pt A):2-14. PubMed ID: 26706569
[TBL] [Abstract][Full Text] [Related]
17. Generation of Transplantable Retinal Pigmented Epithelial (RPE) Cells for Treatment of Age-Related Macular Degeneration (AMD).
Surendran H; Rathod RJ; Pal R
Methods Mol Biol; 2019; 2045():283-298. PubMed ID: 29896658
[TBL] [Abstract][Full Text] [Related]
18. Stemming retinal regeneration with pluripotent stem cells.
Jin ZB; Gao ML; Deng WL; Wu KC; Sugita S; Mandai M; Takahashi M
Prog Retin Eye Res; 2019 Mar; 69():38-56. PubMed ID: 30419340
[TBL] [Abstract][Full Text] [Related]
19. Differentiation of human pluripotent stem cells to retinal pigmented epithelium in defined conditions using purified extracellular matrix proteins.
Rowland TJ; Blaschke AJ; Buchholz DE; Hikita ST; Johnson LV; Clegg DO
J Tissue Eng Regen Med; 2013 Aug; 7(8):642-53. PubMed ID: 22514096
[TBL] [Abstract][Full Text] [Related]
20. Langmuir-Schaefer film deposition onto honeycomb porous films for retinal tissue engineering.
Calejo MT; Ilmarinen T; Vuorimaa-Laukkanen E; Talvitie E; Hakola HM; Skottman H; Kellomäki M
Acta Biomater; 2017 May; 54():138-149. PubMed ID: 28223209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
